Gremlin-1 in Pregnancy and Postpartum: Relation to the Fatty Liver Index, Markers of Bone Health, Glucose Metabolism and Gestational Diabetes Mellitus Status

Overview

Journal Acta Diabetol

Specialty Endocrinology

Date 2023 Jul 30

PMID 37518503

Authors

Carola Deischinger

Magdalena Bastian

Karoline Leitner

Dagmar Bancher-Todesca

Herbert Kiss

Sabina Baumgartner-Parzer

Alexandra Kautzky-Willer

Jurgen Harreiter

Affiliations

Soon will be listed here.

Abstract

Introduction: Gremlin-1 is a peptide that functions as an antagonist to bone morphogenic proteins and is overexpressed in obesity and type 2 diabetes mellitus. Gremlin-1 has not yet been investigated in pregnancy, pregnancy-related insulin resistance or gestational diabetes mellitus (GDM).

Patients And Methods: Gremlin-1 levels were measured throughout the pregnancy of 58 women at high risk for GDM at the Medical University of Vienna. Furthermore, an oral glucose tolerance test, fasting insulin, fasting glucose, sex hormones, blood lipids, liver and renal parameters, and markers of bone development were evaluated at two points during pregnancy (< 20 weeks of gestation (GW), GW 24-28) and 12-14 weeks postpartum.

Results: Gremlin-1 levels decreased from < 20 GW (mean = 9.2 pg/ml, SD = 8.4 pg/ml) to GW 24-28 (mean = 6.7 pg/ml, SD = 5.7 pg/ml, p = 0.033) and increased again postpartum, albeit not significantly (mean = 10.7 pg/ml, SD = 13.1 pg/ml, p = 0.339). During pregnancy, Gremlin-1 levels correlated negatively with osteocalcin and procollagen type I aminoterminal propeptide (P1NP), markers of bone health. Concerning glucose metabolism, Gremlin-1 levels were inversely related to the Insulinogenic Index at GW < 20. However, Gremlin-1 levels were not significantly different between women with normal glucose tolerance and GDM during pregnancy. Postpartum, Gremlin-1 was associated with the fatty liver index, osteocalcin levels, diastolic blood pressure and weight.

Conclusion: Gremlin-1 levels decreased significantly during pregnancy. The biomarker is not related to GDM status, but correlates negatively with the Insulinogenic Index, an index related to beta cell function. Trial Registry Number ACTRN12616000924459.

References

Gustafson B, Hammarstedt A, Hedjazifar S, M Hoffmann J, Svensson P, Grimsby J . BMP4 and BMP Antagonists Regulate Human White and Beige Adipogenesis. Diabetes. 2015; 64(5):1670-81. DOI: 10.2337/db14-1127. View

M Hoffmann J, Grunberg J, Church C, Elias I, Palsdottir V, Jansson J . BMP4 Gene Therapy in Mature Mice Reduces BAT Activation but Protects from Obesity by Browning Subcutaneous Adipose Tissue. Cell Rep. 2017; 20(5):1038-1049. DOI: 10.1016/j.celrep.2017.07.020. View

Catalano P, McIntyre H, Cruickshank J, McCance D, Dyer A, Metzger B . The hyperglycemia and adverse pregnancy outcome study: associations of GDM and obesity with pregnancy outcomes. Diabetes Care. 2012; 35(4):780-6. PMC: 3308300. DOI: 10.2337/dc11-1790. View

Elemam N, Imadeddin Malek A, Mahmoud E, El-Huneidi W, Talaat I . Insights into the Role of Gremlin-1, a Bone Morphogenic Protein Antagonist, in Cancer Initiation and Progression. Biomedicines. 2022; 10(2). PMC: 8869528. DOI: 10.3390/biomedicines10020301. View

SELTZER H, Allen E, Herron Jr A, Brennan M . Insulin secretion in response to glycemic stimulus: relation of delayed initial release to carbohydrate intolerance in mild diabetes mellitus. J Clin Invest. 1967; 46(3):323-35. PMC: 297053. DOI: 10.1172/JCI105534. View

Muller I, Schneider M, Muller K, Lunov O, Borst O, Simmet T . Protective role of Gremlin-1 in myocardial function. Eur J Clin Invest. 2021; 51(7):e13539. DOI: 10.1111/eci.13539. View

Kisonaite M, Wang X, Hyvonen M . Structure of Gremlin-1 and analysis of its interaction with BMP-2. Biochem J. 2016; 473(11):1593-604. PMC: 4888461. DOI: 10.1042/BCJ20160254. View

Winhofer Y, Handisurya A, Tura A, Bittighofer C, Klein K, Schneider B . Osteocalcin is related to enhanced insulin secretion in gestational diabetes mellitus. Diabetes Care. 2009; 33(1):139-43. PMC: 2797959. DOI: 10.2337/dc09-1237. View

Bedogni G, Bellentani S, Miglioli L, Masutti F, Passalacqua M, Castiglione A . The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol. 2006; 6:33. PMC: 1636651. DOI: 10.1186/1471-230X-6-33. View

10.

Kruszewska J, Laudy-Wiaderny H, Kunicki M . Review of Novel Potential Insulin Resistance Biomarkers in PCOS Patients-The Debate Is Still Open. Int J Environ Res Public Health. 2022; 19(4). PMC: 8871992. DOI: 10.3390/ijerph19042099. View

11.

Nolan K, Kattamuri C, Rankin S, Read R, Zorn A, Thompson T . Structure of Gremlin-2 in Complex with GDF5 Gives Insight into DAN-Family-Mediated BMP Antagonism. Cell Rep. 2016; 16(8):2077-2086. PMC: 5001929. DOI: 10.1016/j.celrep.2016.07.046. View

12.

Levy J, Matthews D, Hermans M . Correct homeostasis model assessment (HOMA) evaluation uses the computer program. Diabetes Care. 1998; 21(12):2191-2. DOI: 10.2337/diacare.21.12.2191. View

13.

Banerjee R . Piecing together the puzzle of pancreatic islet adaptation in pregnancy. Ann N Y Acad Sci. 2018; 1411(1):120-139. DOI: 10.1111/nyas.13552. View

14.

Utzschneider K, Prigeon R, Faulenbach M, Tong J, Carr D, Boyko E . Oral disposition index predicts the development of future diabetes above and beyond fasting and 2-h glucose levels. Diabetes Care. 2008; 32(2):335-41. PMC: 2628704. DOI: 10.2337/dc08-1478. View

15.

Koli K, Myllarniemi M, Vuorinen K, Salmenkivi K, Ryynanen M, Kinnula V . Bone morphogenetic protein-4 inhibitor gremlin is overexpressed in idiopathic pulmonary fibrosis. Am J Pathol. 2006; 169(1):61-71. PMC: 1698771. DOI: 10.2353/ajpath.2006.051263. View

16.

Roxburgh S, Murphy M, Pollock C, Brazil D . Recapitulation of embryological programmes in renal fibrosis--the importance of epithelial cell plasticity and developmental genes. Nephron Physiol. 2006; 103(3):p139-48. DOI: 10.1159/000092453. View

17.

Jelsma J, Van Poppel M, Galjaard S, Desoye G, Corcoy R, Devlieger R . DALI: Vitamin D and lifestyle intervention for gestational diabetes mellitus (GDM) prevention: an European multicentre, randomised trial - study protocol. BMC Pregnancy Childbirth. 2013; 13:142. PMC: 3710199. DOI: 10.1186/1471-2393-13-142. View

18.

Deischinger C, Harreiter J, Leitner K, Wattar L, Baumgartner-Parzer S, Kautzky-Willer A . Glypican-4 in pregnancy and its relation to glucose metabolism, insulin resistance and gestational diabetes mellitus status. Sci Rep. 2021; 11(1):23898. PMC: 8668887. DOI: 10.1038/s41598-021-03454-x. View

19.

Hammarstedt A, Gogg S, Hedjazifar S, Nerstedt A, Smith U . Impaired Adipogenesis and Dysfunctional Adipose Tissue in Human Hypertrophic Obesity. Physiol Rev. 2018; 98(4):1911-1941. DOI: 10.1152/physrev.00034.2017. View

20.

Deischinger C, Leitner K, Baumgartner-Parzer S, Bancher-Todesca D, Kautzky-Willer A, Harreiter J . CTRP-1 levels are related to insulin resistance in pregnancy and gestational diabetes mellitus. Sci Rep. 2020; 10(1):17345. PMC: 7562865. DOI: 10.1038/s41598-020-74413-1. View